Physician

Ali-Reza Golshayan, MD

According to 2025 Medicare claims, Ali-Reza Golshayan, MD (NPI: 1093990814) practices medical oncology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Gaston, NC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1053805127; TIN: 56-0529945) and primary practice location at 28054-0637. Golshayan is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Golshayan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 276 traditional Medicare patients, billed 99,863 HCPCS/CPT codes, and received $1,396,309 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,293 prescription claims across 204 beneficiaries totaling $2,704,656 in drug costs, led by Lenalidomide (Lenalidomide). 2021 DME data shows 36 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $665,862 to $2,704,656. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	992	119,300	$1,409,142
2016	968	125,944	$1,233,013
2017	961	135,399	$1,343,555
2018	934	113,664	$1,198,854
2019	379	111,132	$1,099,999
2020	326	89,041	$734,396
2021	300	80,529	$1,078,250
2022	244	51,904	$867,594
2023	244	68,538	$1,240,648
2024	276	99,863	$1,396,309

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	151	570	$665,862
2016	135	620	$345,336
2017	143	648	$788,067
2018	131	348	$331,042
2019	147	840	$1,902,926
2020	135	911	$1,576,017
2021	137	1,017	$2,223,109
2022	163	1,030	$2,622,746
2023	173	1,174	$3,118,080
2024	204	1,293	$2,704,656

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	63	$1,471
2016	N/R	N/R	N/R
2017	14	16	$2,143
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	27	$2,781
2021	N/R	36	$3,702
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	62	147	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	125	337	$88
80053	Blood test, comprehensive group of blood chemicals	180	751	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	162	593	$8
83615	Lactate dehydrogenase (enzyme) level	80	190	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	26	728	$318,866
Imbruvica	Ibrutinib	29	842	$288,656
Inlyta	Axitinib	13	390	$272,432
Jakafi	Ruxolitinib Phosphate	22	660	$270,410
Ibrance	Palbociclib	15	420	$230,465

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Ali-Reza Golshayan, MD?

Tedicare shows public-source Medicare data for Ali-Reza Golshayan, MD (NPI 1093990814), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali-Reza Golshayan, MD have ACO affiliation data?

Ali-Reza Golshayan, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Ali-Reza Golshayan, MD?

Ali-Reza Golshayan, MD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1053805127) in the available physician profile data.

Does Ali-Reza Golshayan, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.